Annual report pursuant to Section 13 and 15(d)

Acquisitions and Loss on Impairment of TLL, LLC (Tables)

v3.7.0.1
Acquisitions and Loss on Impairment of TLL, LLC (Tables)
12 Months Ended
Jan. 31, 2017
DCC Labs [Member]  
Summary of Allocation of Purchase Price

The allocation of purchase price was as follows (amounts in thousands):

 

Estimated Fair value of consideration:

  

Cash, net of cash acquired

   $ 5,243  

Stock consideration

     2,640  
  

 

 

 

Total purchase price

   $ 7,883  
  

 

 

 

Estimated Fair value of assets acquired and liabilities assumed:

  

Current assets

     826  

Other long-term assets

     116  

Finite-life intangible assets

     810  

Goodwill

     7,255  

Current liabilities

     (618

Other long-term liabilities

     (506
  

 

 

 

Allocated purchase price

   $ 7,883  
  

 

 

 
Timeline Labs [Member]  
Summary of Allocation of Purchase Price

The allocation of the purchase price was as follows (amounts in thousands):

 

Fair value of consideration:

  

Cash, net of cash acquired

   $ 14,186  

Closing stock consideration

     3,019  

Deferred stock consideration

     4,959  

Contingent consideration

     475  
  

 

 

 

Total purchase price

   $ 22,639  
  

 

 

 

Fair value of assets acquired and liabilities assumed:

  

Current assets

     95  

Other long-term assets

     108  

Finite-life intangible assets

     6,720  

Goodwill

     15,787  

Current liabilities

     (71
  

 

 

 

Allocated purchase price

   $ 22,639